Pharnext
US Patent 8,571,809. Apparatus for calculating scores of chains for sequence alignments. Inventor: Gregory Knowles. Assignee: Bioinformatics Systems
Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
Premium
The figure comes from a report commissioned by proteomics firm Proteome Sciences, which, like a number of other protein biomarker firms including Quanterix, Rules-Based Medicine, and NextGen Sciences, has made AD a significant focus of its R&D and commercialization efforts.
BSI Partnering with Pharnext on $14.2M Initiative to Develop Biomarkers and Therapeutics for AD
Premium
Funded by the French innovation agency OSEO, the collaboration calls for the companies to develop a prototype blood-based protein biomarker test for Alzheimer's disease as well as a therapeutic for the disease and a companion diagnostic.